SI-BONE, INC. Debt Securities, Available-for-sale, Amortized Cost
SI-BONE, INC. (SIBN) had Debt Securities, Available-for-sale, Amortized Cost of $102.71 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2019-05-09
- 2019-03-31: Debt Securities, Available-for-sale, Amortized Cost $102.71M.
- 2018-12-31: Debt Securities, Available-for-sale, Amortized Cost $97.09M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2019-03-31 | $102.71M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $97.09M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |